In this virtual tumor board, Vicki L. Keedy, MD, MSCI, Brian P. Rubin, MD, PhD, and Kathleen Polson, NP, discuss diagnostic evaluation, treatment selection, and supportive care strategies for patients with soft tissue sarcoma.
In this CME/NCPD activity, Mark G. Kris, MD, and Nathan Pennell, MD, discuss how the potential for CNS disease and acquired resistance mutations can infuence treatment selection for NSCLC and evaluate the efficacy of novel therapies for NSCLC. Also available as a bonus episode for our Oncology Data Advsior podcast!
In this NCPD activity, Amy L. Goodrich, RN, MSN, CRNP-AC, evaluates guideline recommendations for the management of patients with advanced NHL, assesses emerging efficacy and safety data on novel therapies for advanced NHL, and applies strategies to manage adverse events and optimize treatment experiences for patients receiving novel therapies for NHL. Start now!
This NCPD activity, presented by Allison Miller Imahiyerobo, APN, includes cases that provide insight into nursing management of ITP. In addition, Ms. Miller Imahiyerobo discusses the pathogenesis of ITP and differentiates the efficacy and safety profiles of current and emerging ITP therapies.
In this virtual tumor board, David P. Steensma, MD, FACP, Reza Nejati, MD, and Ilene Galinsky, BSN, MSN, ANP-C, discuss patient and tumor characteristics that inform personalized care plans, risk stratification, and supportive care strategies for patients with MDS.
VTE is a common and potentially life-threatening complication in patients with cancer. This online activity reviews VTE pathophysiology, risk assessment, and supportive care interventions for ambulatory cancer patients.